H.C. Wainwright analyst Joseph Pantginis raised the price target on Lexicon Pharmaceuticals (NASDAQ: LXRX) to $6.00 (from $4.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE